hypersensitivity to fluoroquinolones; viral infections of the ear canal; fungal infections of the ear canal; tuberculous infections of the ear

discontinue at first sign of skin rash; prolonged use may result in overgrowth of non-susceptible organisms

anaphylaxis — requires immediate medical attention; hypersensitivity reaction — requires immediate medical attention

indicated to manage bacterial ear infections and formulated to alleviate inflammation and oedema within the ear canal.

This product combines a fluoroquinolone antibiotic, which inhibits bacterial DNA gyrase and topoisomerase IV, with a potent corticosteroid that suppresses the inflammatory response by inducing phospholipase A2 inhibitory proteins.

Pregnancy: Use only if the potential benefit outweighs the risk to the foetus. Breastfeeding: Use with caution; systemic absorption is minimal.